Placental urocortin-2 and -3: Endocrine or Paracrine Functioning During Healthy Pregnancy?

Placenta

Volumn 31, Issue 6, 2010, Pages 475-481

  Pepels, P P L M ^a,b   Spaanderman, M E A ^b   Hermus, A R M M ^b   Lotgering, F K ^b   Sweep, C G J ^a  

^a Laboratory of Genetic Endocrine and Metabolic Diseases   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CRH; E2; Estrogens; Placenta; Plasma; Ucn2; Ucn3; Urocortin

Indexed keywords

ANTISAUVAGINE 30; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; ESTRADIOL; UROCORTIN II; UROCORTIN III;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOCRINE FUNCTION; ESTROGEN RELEASE; ESTROGEN SYNTHESIS; FEMALE; GESTATIONAL AGE; HUMAN; IN VITRO STUDY; NORMAL HUMAN; PARACRINE SIGNALING; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RADIOIMMUNOASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORTICOTROPIN-RELEASING HORMONE; CROSS-SECTIONAL STUDIES; ESTRADIOL; FEMALE; HUMANS; PARACRINE COMMUNICATION; PATIENT SELECTION; PLACENTA; PREGNANCY; RADIOIMMUNOASSAY; TISSUE CULTURE TECHNIQUES; UROCORTINS;

EID: 77952546242     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2010.03.012     Document Type: Article

References (34)

1. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., Donaldson C., et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A 98 (2001) 7570-7575
2. Hsu S.Y., and Hsueh A.J.W. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7 (2001) 605-611
3. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., et al. Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci U S A 98 (2001) 2843-2848
4. Karteris E., Hillhouse E.W., and Grammatopoulos D.K. Urocortin 2 is expressed in human pregnant myometrial cells and regulates mysosin light chain phosphorylation: potential role of the type 2 corticotropin-releasing hormone recepteor in the control of the myometrial contractility. Endocrinology 145 (2004) 890-900
5. Grammatopoulos D.K., Randeva H.S., Levine M.A., Katsanou E.S., and Hilhouse E.W. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1 alpha and R2 beta CRH receptor subtypes and stimulation of Gq-proteins. Mol Endocrinol 14 (2000) 2076-2091
6. Imperatore A., Rolfo A., Petraglia F., Challis J.R.G., and Caniggia I. Urocortin 2 and 3 mRNA and protein expression are increased in preeclamptic placentae specimens. Reprod Sci 15 60 (2008) 78A 15:317A-17A
7. Florio P., Franchini A., Reis F.M., Pezzani I., Ottaviani E., and Petraglia F. Human placenta, chorion, amnion and decidua express different variants of corticotropin-releasing factor receptor messenger RNA. Placenta 21 (2000) 32-37
8. Florio P., Vale W., and Petraglia F. Urocortins in human reproduction. Peptides 25 (2004) 1751-1757
9. Smith R. Mechanisms of disease - parturition. N Engl J Med 356 (2007) 271-283
10. McLean M., Bisits A., Davies J., Woods R., Lowry P., and Smith R. A placental clock controlling the length of human-pregnancy. Nat Med 1 (1995) 460-463
11. Sirianni R., Rehman K.S., Carr B.R., Parker C.R., and Rainey W.E. Corticotropin-releasing hormone directly stimulates cortisol and the cortisol biosynthetic pathway in human fetal adrenal cells. J Clin Endocrinol Metabol 90 (2005) 279-285
12. Smith R., Mesiano S., Chan E.C., Brown S., and Jaffe R.B. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J Clin Endocrinol Metabol 83 (1998) 2916-2920
13. You X.J., Yang R.F., Tang X.L., Gao L., and Ni X. Corticotropin-releasing hormone stimulates estrogen biosynthesis in cultured human placental trophoblasts. Biol Reprod 74 (2006) 1067-1072
14. Florio P., Severi F.M., Ciarmela P., Fiore G., Calonaci G., Merola A., et al. Placental stress factors and maternal-fetal adaptive response - the corticotropin-releasing factor family. Endocrine 19 (2002) 91-102
15. Challis J.R.G., Matthews S.G., Gibb W., and Lye S.J. Endocrine and paracrine regulation of birth at term and preterm. Endocrine Rev 21 (2000) 514-550
16. Romero R., Scoccia B., Mazor M., Wu Y.K., and Beneveniste R. Evidence for a local change in the progesterone ratio in human parturition. Am J Obstet Gynecol 159 (1988) 657-660
17. Avrech O.M., Golan A., Weinraub Z., Bukovsky I., and Caspi E. Mifepristone (RU486) alone or in combination with prostaglandin analogue for termination of early pregnancy: a review. Fertil Steril 56 (1991) 385-393
18. Pepels P.P.L.M., Spaanderman M.E.A., Bulten J., Smits P.A.B.M., Hermus A.R.M.M., Lotgering F.K., et al. Placental urocortins and CRF in late gestation. Placenta 30 (2009) 483-490
19. Pepels P.P.L.M., Pesman G., Korsten H., Wendelaar Bonga S.E., and Balm P.H.M. Corticotropin-releasing hormone (CRH) in the teleost fish Oreochromis mossambicus (tilapia): in vitro release and brain distribution determined by a novel radioimmunoassay. Peptides 23 (2002) 1053-1062
20. Wetzka B., Schafer W., Scheibel M., Nusing R., and Zahradnik H.P. Eicosanoid production in intrauterine tissues before and after labor in short-term tissue culture. Prostaglandins 45 (1993) 571-581
21. Zicarri A., Ticconi C., Pontieri G., Loyola G., and Piccione E. Effects of glucocorticoids and progesterone on prostaglandin E2 and leukotriene B4 release by human fetal membranes at term gestation. Prostaglandins 54 (1997) 571-581
22. Petraglia F., Florio P., Benedetto C., Marozio L., Di Blasio A.M., Ticconi C., et al. Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro. J Clin Endocrinol Metabol 84 (1999) 1420-1423
23. Higelina J., Py-Langa G., Paternosterb C., Ellisc G.J., and Patelb A. F.M.D. 125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors. Neuropharmacology 40 (2000) 114-122
24. Takahashi K., Totsune K., Murakami O., Saruta M., Nakabayashi M., Suzuki T., et al. Expression of urocortin III/stresscopin in human heart and kidney. JJ Clin Endocrinol Metabol 89 (2004) 1897-1903
25. Dautzenberg F.M., and Hauger R.L. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 23 (2002) 71-77
26. Watanabe F., Oki Y., Ozawa M., Masuzawa M., Iwabuchi M., Yoshimi T., et al. Urocortin in human placenta and maternal plasma. Peptides 20 (1999) 205-209
27. Clifton V.L., Qing G., Murphy V.E., Schwartz J., Madsen G., and Smith R. Localization and characterization of urocortin during human pregnancy. Placenta 21 (2000) 782-788
28. Glynn B.P., Wolton A., Rodriguez-Linares B., Phaneuf S., and Linton E.A. Urocortin in pregnancy. Am J Obstet Gynecol 179 (1998) 533-539
29. Florio P., Cobellis L., Woodman J., Severi F.M., Linton E.A., and Petraglia F. Levels of maternal plasma corticotropin-releasing factor and urocortin during labor. J Soc Gynecol Invest 9 (2002) 233-237
30. Florio P., Rivest S., Reist F.M., Simoncini T., Martinelli P., Genazzani A.R., et al. Lack of gestation-related changes of urocortin gene expression in human placenta. Prenat Neonat Med 4 (1999) 296-300
31. Florio P., Torricelli M., De Falco G., Leucci E., Giovannelli A., Gazzolo D., et al. High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension. J Hypertension 24 (2006) 1831-1840
32. Yang R.F., You X.J., Tang X.L., Gao L., and Ni X. Corticotropin-releasing hormone inhibits progesterone production in cultured human placental trophoblasts. Mol Endocrinol 37 (2006) 533-540
33. Imperatore A., Li W., Petraglia F., and Challis J.R.G. Urocortin 2 stimulates estradiol secretion from cultured human placental cells: an effect mediated by the type 2 corticotrophin-releasing hormone (CRH) receptor. Reproduct Sci 16 (2009) 551-558
34. Nathanielsz P.W., Jenkins S.L., Tame J.D., Winter J.A., Guller S., and Giussani D.A. Local paracrine effects of estradiol are central to parturition in the rhesus monkey. Nat Med 4 (1998) 456-459